Industry: Medical Devices & Consumables
Published Date: 2024-04-12
Pages: 106 Pages
Report ld: 2933949
Request Sample
Customized Report
Chromosomal Microarray Market Size(US$)

CAGR 2024-2030
8.8%
Market Size,2030
USD 2,703.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Market Analysis and Insights: Global Chromosomal Microarray Market
The global Chromosomal Microarray market is projected to grow from US$ 1630 million in 2024 to US$ 2703.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.8% during the forecast period.
The global chromosomal microarray market is a growing segment of the molecular diagnostics industry that focuses on the use of chromosomal microarray analysis (CMA) technology for genetic testing. CMA is a high-resolution technique used to detect chromosomal abnormalities and copy number variations (CNVs) in an individual’s DNA.
Here are some key insights into the global chromosomal microarray market:
Market Size and Growth: The global chromosomal microarray market has witnessed significant growth in recent years and is expected to continue expanding. Factors driving market growth include increasing awareness and adoption of CMA as a diagnostic tool, advancements in genomic technologies, and a growing prevalence of genetic disorders and developmental disabilities.
Application Areas: Chromosomal microarray analysis is used in various clinical applications, including prenatal testing, postnatal testing, cancer diagnostics, and research applications. In the prenatal setting, CMA is commonly used for detecting chromosomal abnormalities in fetuses, including common conditions such as Down syndrome. In postnatal testing, CMA helps identify genetic causes of developmental delays, intellectual disabilities, and autism spectrum disorders, among others.
Technological Advancements: The chromosomal microarray market is witnessing continuous technological advancements in terms of higher resolution arrays, improved detection sensitivity, and enhanced analysis software. These advancements enable more accurate and comprehensive detection of genomic abnormalities, driving the market’s growth.
Market Players: The global chromosomal microarray market is highly competitive, with several established players and emerging companies. Some of the key players in the market include Agilent Technologies Inc., Illumina Inc., Oxford Gene Technology Ltd., PerkinElmer Inc., Affymetrix Inc. (Thermo Fisher Scientific), and Applied Microarrays Inc., among others. These companies are investing in research and development to improve their CMA offerings and expand their market presence.
Regional Analysis: North America accounts for a significant share of the global chromosomal microarray market, attributed to the presence of key market players, advanced healthcare infrastructure, and high awareness and adoption rates of genetic testing. Europe and the Asia-Pacific region are also witnessing significant growth in the field, driven by expanding healthcare infrastructure, increasing focus on personalized medicine, and rising demand for genetic testing services.
Regulatory Standards: Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established guidelines and standards for the use of CMA in clinical diagnostics. Compliance with these regulations and obtaining necessary approvals or clearances is essential for market entry and commercialization of CMA products.
Collaborations and Partnerships: Companies operating in the chromosomal microarray market often engage in collaborations, partnerships, and strategic alliances to enhance their product offerings, expand their geographic presence, and leverage complementary expertise. These collaborations aim to accelerate innovation and provide comprehensive genetic testing solutions to healthcare providers worldwide.
In summary, the global chromosomal microarray market is experiencing steady growth driven by advancements in genomic technologies, increasing prevalence of genetic disorders, and growing adoption of genetic testing for personalized medicine. The market is characterized by the presence of established players and continuous investments in research and development. As awareness and demand for chromosomal microarray analysis increase, the market is expected to expand further in the coming years.The global chromosomal microarray market is a growing segment of the molecular diagnostics industry that focuses on the use of chromosomal microarray analysis (CMA) technology for genetic testing. CMA is a high-resolution technique used to detect chromosomal abnormalities and copy number variations (CNVs) in an individual’s DNA.
Here are some key insights into the global chromosomal microarray market:
Market Size and Growth: The global chromosomal microarray market has witnessed significant growth in recent years and is expected to continue expanding. Factors driving market growth include increasing awareness and adoption of CMA as a diagnostic tool, advancements in genomic technologies, and a growing prevalence of genetic disorders and developmental disabilities.
Application Areas: Chromosomal microarray analysis is used in various clinical applications, including prenatal testing, postnatal testing, cancer diagnostics, and research applications. In the prenatal setting, CMA is commonly used for detecting chromosomal abnormalities in fetuses, including common conditions such as Down syndrome. In postnatal testing, CMA helps identify genetic causes of developmental delays, intellectual disabilities, and autism spectrum disorders, among others.
Technological Advancements: The chromosomal microarray market is witnessing continuous technological advancements in terms of higher resolution arrays, improved detection sensitivity, and enhanced analysis software. These advancements enable more accurate and comprehensive detection of genomic abnormalities, driving the market’s growth.
Market Players: The global chromosomal microarray market is highly competitive, with several established players and emerging companies. Some of the key players in the market include Agilent Technologies Inc., Illumina Inc., Oxford Gene Technology Ltd., PerkinElmer Inc., Affymetrix Inc. (Thermo Fisher Scientific), and Applied Microarrays Inc., among others. These companies are investing in research and development to improve their CMA offerings and expand their market presence.
Regional Analysis: North America accounts for a significant share of the global chromosomal microarray market, attributed to the presence of key market players, advanced healthcare infrastructure, and high awareness and adoption rates of genetic testing. Europe and the Asia-Pacific region are also witnessing significant growth in the field, driven by expanding healthcare infrastructure, increasing focus on personalized medicine, and rising demand for genetic testing services.
Regulatory Standards: Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established guidelines and standards for the use of CMA in clinical diagnostics. Compliance with these regulations and obtaining necessary approvals or clearances is essential for market entry and commercialization of CMA products.
Collaborations and Partnerships: Companies operating in the chromosomal microarray market often engage in collaborations, partnerships, and strategic alliances to enhance their product offerings, expand their geographic presence, and leverage complementary expertise. These collaborations aim to accelerate innovation and provide comprehensive genetic testing solutions to healthcare providers worldwide.
In summary, the global chromosomal microarray market is experiencing steady growth driven by advancements in genomic technologies, increasing prevalence of genetic disorders, and growing adoption of genetic testing for personalized medicine. The market is characterized by the presence of established players and continuous investments in research and development. As awareness and demand for chromosomal microarray analysis increase, the market is expected to expand further in the coming years.
Report Covers:
This report presents an overview of global market for Chromosomal Microarray market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Chromosomal Microarray, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Chromosomal Microarray, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Chromosomal Microarray revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Chromosomal Microarray market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Chromosomal Microarray revenue, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chromosomal Microarray Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Xon Array
1.2.3 750K Array
1.2.4 Optima Array
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chromosomal Microarray Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Autism
1.3.3 Angelman Syndrome
1.3.4 Williams Syndrome
1.3.5 DiGeorge Syndrome
1.3.6 Prader-Willi Syndrome
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chromosomal Microarray Market Perspective (2019-2030)
2.2 Global Chromosomal Microarray Growth Trends by Region
2.2.1 Chromosomal Microarray Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chromosomal Microarray Historic Market Size by Region (2019-2024)
2.2.3 Chromosomal Microarray Forecasted Market Size by Region (2025-2030)
2.3 Chromosomal Microarray Market Dynamics
2.3.1 Chromosomal Microarray Industry Trends
2.3.2 Chromosomal Microarray Market Drivers
2.3.3 Chromosomal Microarray Market Challenges
2.3.4 Chromosomal Microarray Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Chromosomal Microarray by Players
3.1.1 Global Chromosomal Microarray Revenue by Players (2019-2024)
3.1.2 Global Chromosomal Microarray Revenue Market Share by Players (2019-2024)
3.2 Global Chromosomal Microarray Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Chromosomal Microarray, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Chromosomal Microarray Market Concentration Ratio
3.4.1 Global Chromosomal Microarray Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chromosomal Microarray Revenue in 2023
3.5 Global Key Players of Chromosomal Microarray Head office and Area Served
3.6 Global Key Players of Chromosomal Microarray, Product and Application
3.7 Global Key Players of Chromosomal Microarray, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chromosomal Microarray Breakdown Data by Type
4.1 Global Chromosomal Microarray Historic Market Size by Type (2019-2024)
4.2 Global Chromosomal Microarray Forecasted Market Size by Type (2025-2030)
5 Chromosomal Microarray Breakdown Data by Application
5.1 Global Chromosomal Microarray Historic Market Size by Application (2019-2024)
5.2 Global Chromosomal Microarray Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chromosomal Microarray Market Size (2019-2030)
6.2 North America Chromosomal Microarray Market Size by Type
6.2.1 North America Chromosomal Microarray Market Size by Type (2019-2024)
6.2.2 North America Chromosomal Microarray Market Size by Type (2025-2030)
6.2.3 North America Chromosomal Microarray Market Share by Type (2019-2030)
6.3 North America Chromosomal Microarray Market Size by Application
6.3.1 North America Chromosomal Microarray Market Size by Application (2019-2024)
6.3.2 North America Chromosomal Microarray Market Size by Application (2025-2030)
6.3.3 North America Chromosomal Microarray Market Share by Application (2019-2030)
6.4 North America Chromosomal Microarray Market Size by Country
6.4.1 North America Chromosomal Microarray Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Chromosomal Microarray Market Size by Country (2019-2024)
6.4.3 North America Chromosomal Microarray Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Chromosomal Microarray Market Size (2019-2030)
7.2 Europe Chromosomal Microarray Market Size by Type
7.2.1 Europe Chromosomal Microarray Market Size by Type (2019-2024)
7.2.2 Europe Chromosomal Microarray Market Size by Type (2025-2030)
7.2.3 Europe Chromosomal Microarray Market Share by Type (2019-2030)
7.3 Europe Chromosomal Microarray Market Size by Application
7.3.1 Europe Chromosomal Microarray Market Size by Application (2019-2024)
7.3.2 Europe Chromosomal Microarray Market Size by Application (2025-2030)
7.3.3 Europe Chromosomal Microarray Market Share by Application (2019-2030)
7.4 Europe Chromosomal Microarray Market Size by Country
7.4.1 Europe Chromosomal Microarray Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Chromosomal Microarray Market Size by Country (2019-2024)
7.4.3 Europe Chromosomal Microarray Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Chromosomal Microarray Market Size (2019-2030)
8.2 China Chromosomal Microarray Market Size by Type
8.2.1 China Chromosomal Microarray Market Size by Type (2019-2024)
8.2.2 China Chromosomal Microarray Market Size by Type (2025-2030)
8.2.3 China Chromosomal Microarray Market Share by Type (2019-2030)
8.3 China Chromosomal Microarray Market Size by Application
8.3.1 China Chromosomal Microarray Market Size by Application (2019-2024)
8.3.2 China Chromosomal Microarray Market Size by Application (2025-2030)
8.3.3 China Chromosomal Microarray Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Chromosomal Microarray Market Size (2019-2030)
9.2 Asia Chromosomal Microarray Market Size by Type
9.2.1 Asia Chromosomal Microarray Market Size by Type (2019-2024)
9.2.2 Asia Chromosomal Microarray Market Size by Type (2025-2030)
9.2.3 Asia Chromosomal Microarray Market Share by Type (2019-2030)
9.3 Asia Chromosomal Microarray Market Size by Application
9.3.1 Asia Chromosomal Microarray Market Size by Application (2019-2024)
9.3.2 Asia Chromosomal Microarray Market Size by Application (2025-2030)
9.3.3 Asia Chromosomal Microarray Market Share by Application (2019-2030)
9.4 Asia Chromosomal Microarray Market Size by Region
9.4.1 Asia Chromosomal Microarray Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Chromosomal Microarray Market Size by Region (2019-2024)
9.4.3 Asia Chromosomal Microarray Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Chromosomal Microarray Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Type
10.2.1 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Chromosomal Microarray Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Application
10.3.1 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Chromosomal Microarray Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Country
10.4.1 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Chromosomal Microarray Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Details
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Chromosomal Microarray Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Chromosomal Microarray Business (2019-2024)
11.1.5 Thermo Fisher Scientific Inc. Recent Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Chromosomal Microarray Introduction
11.2.4 Bio-Rad Laboratories Revenue in Chromosomal Microarray Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Developments
11.3 MedGenome
11.3.1 MedGenome Company Details
11.3.2 MedGenome Business Overview
11.3.3 MedGenome Chromosomal Microarray Introduction
11.3.4 MedGenome Revenue in Chromosomal Microarray Business (2019-2024)
11.3.5 MedGenome Recent Developments
11.4 Scott Minifab
11.4.1 Scott Minifab Company Details
11.4.2 Scott Minifab Business Overview
11.4.3 Scott Minifab Chromosomal Microarray Introduction
11.4.4 Scott Minifab Revenue in Chromosomal Microarray Business (2019-2024)
11.4.5 Scott Minifab Recent Developments
11.5 Agilent Technologies Inc.
11.5.1 Agilent Technologies Inc. Company Details
11.5.2 Agilent Technologies Inc. Business Overview
11.5.3 Agilent Technologies Inc. Chromosomal Microarray Introduction
11.5.4 Agilent Technologies Inc. Revenue in Chromosomal Microarray Business (2019-2024)
11.5.5 Agilent Technologies Inc. Recent Developments
11.6 Perkin Elmer Inc.
11.6.1 Perkin Elmer Inc. Company Details
11.6.2 Perkin Elmer Inc. Business Overview
11.6.3 Perkin Elmer Inc. Chromosomal Microarray Introduction
11.6.4 Perkin Elmer Inc. Revenue in Chromosomal Microarray Business (2019-2024)
11.6.5 Perkin Elmer Inc. Recent Developments
11.7 Illumina Inc.
11.7.1 Illumina Inc. Company Details
11.7.2 Illumina Inc. Business Overview
11.7.3 Illumina Inc. Chromosomal Microarray Introduction
11.7.4 Illumina Inc. Revenue in Chromosomal Microarray Business (2019-2024)
11.7.5 Illumina Inc. Recent Developments
11.8 Microarrays Inc.
11.8.1 Microarrays Inc. Company Details
11.8.2 Microarrays Inc. Business Overview
11.8.3 Microarrays Inc. Chromosomal Microarray Introduction
11.8.4 Microarrays Inc. Revenue in Chromosomal Microarray Business (2019-2024)
11.8.5 Microarrays Inc. Recent Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Chromosomal Microarray Introduction
11.9.4 Merck KGaA Revenue in Chromosomal Microarray Business (2019-2024)
11.9.5 Merck KGaA Recent Developments
11.10 Arrayit Corporation
11.10.1 Arrayit Corporation Company Details
11.10.2 Arrayit Corporation Business Overview
11.10.3 Arrayit Corporation Chromosomal Microarray Introduction
11.10.4 Arrayit Corporation Revenue in Chromosomal Microarray Business (2019-2024)
11.10.5 Arrayit Corporation Recent Developments
11.11 GE Healthcare
11.11.1 GE Healthcare Company Details
11.11.2 GE Healthcare Business Overview
11.11.3 GE Healthcare Chromosomal Microarray Introduction
11.11.4 GE Healthcare Revenue in Chromosomal Microarray Business (2019-2024)
11.11.5 GE Healthcare Recent Developments
11.12 Molecular Devices LLC
11.12.1 Molecular Devices LLC Company Details
11.12.2 Molecular Devices LLC Business Overview
11.12.3 Molecular Devices LLC Chromosomal Microarray Introduction
11.12.4 Molecular Devices LLC Revenue in Chromosomal Microarray Business (2019-2024)
11.12.5 Molecular Devices LLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Chromosomal Microarray was estimated to be worth US$ 1898 million in 2025 and is projected to reach US$ 3398 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 119
USD 3950.00
(Single User License)
The global Chromosomal Microarray market was valued at US$ 1898 million in 2025 and is anticipated to reach US$ 3398 million by 2032, at a CAGR of 8.8% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 113
USD 2900.00
(Single User License)
The global Chromosomal Microarray market size was US$ 1759 million in 2024 and is forecast to a readjusted size of US$ 3149 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 100
USD 4250.00
(Single User License)
The global Chromosomal Microarray market is projected to grow from US$ 1759 million in 2024 to US$ 3149 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 140
USD 4900.00
(Single User License)
The global market for Chromosomal Microarray was valued at US$ 1759 million in the year 2024 and is projected to reach a revised size of US$ 3149 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
The global market for Chromosomal Microarray was estimated to be worth US$ 1759 million in 2024 and is forecast to a readjusted size of US$ 3149 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 106
USD 3950.00
(Single User License)
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published Date: 2024-01-17
Pages: 86
USD 2900.00
(Single User License)
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published Date: 2024-01-10
Pages: 105
USD 3950.00
(Single User License)
The global market for Chromosomal Microarray was estimated to be worth US$ 1898 million in 2025 and is projected to reach US$ 3398 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 119
The global Chromosomal Microarray market was valued at US$ 1898 million in 2025 and is anticipated to reach US$ 3398 million by 2032, at a CAGR of 8.8% from 2026 to 2032.
Published: 2026-04-17
Pages: 113
The global Chromosomal Microarray market size was US$ 1759 million in 2024 and is forecast to a readjusted size of US$ 3149 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 100
The global Chromosomal Microarray market is projected to grow from US$ 1759 million in 2024 to US$ 3149 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 140
The global market for Chromosomal Microarray was valued at US$ 1759 million in the year 2024 and is projected to reach a revised size of US$ 3149 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published: 2025-01-16
Pages: 86
The global market for Chromosomal Microarray was estimated to be worth US$ 1759 million in 2024 and is forecast to a readjusted size of US$ 3149 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 106
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published: 2024-01-17
Pages: 86
A Chromosome Microarray (CMA; also known as a chromosomal microarray or molecular karyotype) is a powerful diagnostic tool that is used to identify genetic causes of illness and developmental problems. It is used to measure the expression of multiple genes simultaneously.
Published: 2024-01-10
Pages: 105
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now